These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 8690968)

  • 1. Alterations in serum lipids in lepromatous leprosy patients with and without ENL reactions and their relationship to acute phase proteins.
    Memon RA; Hussain R; Raynes JG; Lateff A; Chiang TJ
    Int J Lepr Other Mycobact Dis; 1996 Jun; 64(2):115-22. PubMed ID: 8690968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low serum HDL-cholesterol is associated with raised tumor necrosis factor-alpha during ENL reactions.
    Memon RA; Kifayet A; Shahid F; Lateef A; Chiang J; Hussain R
    Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):1-11. PubMed ID: 9207748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and histological discrepancies in diagnosis of ENL reactions classified by assessment of acute phase proteins SAA and CRP.
    Hussain R; Lucas SB; Kifayet A; Jamil S; Raynes J; Uqaili Z; Dockrell HM; Chiang TJ; McAdam KP
    Int J Lepr Other Mycobact Dis; 1995 Jun; 63(2):222-30. PubMed ID: 7602217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum zinc/copper ratio in subtypes of leprosy and effect of oral zinc therapy on reactional states.
    George J; Bhatia VN; Balakrishnan S; Ramu G
    Int J Lepr Other Mycobact Dis; 1991 Mar; 59(1):20-4. PubMed ID: 2030313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased chitotriosidase activity in serum of leprosy patients: association with bacillary leprosy.
    Iyer A; van Eijk M; Silva E; Hatta M; Faber W; Aerts JM; Das PK
    Clin Immunol; 2009 Jun; 131(3):501-9. PubMed ID: 19307157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of serum lipids and lipoproteins in leprosy.
    Ahaley SK; Sardeshmukh AS; Suryakar AN; Samson PD
    Indian J Lepr; 1992; 64(1):91-8. PubMed ID: 1573306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between TNF production, increase of plasma C-reactive protein level and suppression of T lymphocyte response to concanavalin A during erythema nodosum leprosum.
    Foss NT; de Oliveira EB; Silva CL
    Int J Lepr Other Mycobact Dis; 1993 Jun; 61(2):218-26. PubMed ID: 8371031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective decrease of M. leprae-specific IgG1 and IgG3 antibodies in leprosy patients associated with ENL.
    Kifayet A; Hussain R
    Int J Lepr Other Mycobact Dis; 1996 Jun; 64(2):105-14. PubMed ID: 8690967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of prednisolone treatment on serological responses and lipid profiles in Ethiopian leprosy patients with Erythema Nodosum Leprosum reactions.
    Negera E; Tilahun M; Bobosha K; Lambert SM; Walker SL; Spencer JS; Aseffa A; Dockrell HM; Lockwood DN
    PLoS Negl Trop Dis; 2018 Dec; 12(12):e0007035. PubMed ID: 30592714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum proteome of leprosy patients undergoing erythema nodosum leprosum reaction: regulation of expression of the isoforms of haptoglobin.
    Gupta N; Shankernarayan NP; Dharmalingam K
    J Proteome Res; 2007 Sep; 6(9):3669-79. PubMed ID: 17658739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum amyloid protein SAA, C-reactive protein and lysozyme in leprosy.
    Scheinberg MA; Masuda A; Benson MD; Mendes NF
    Int J Lepr Other Mycobact Dis; 1979 Jun; 47(2):133-7. PubMed ID: 572349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alpha-1-antitrypsin in leprosy.
    Deshpande SV; Zawar PB; Chawhan RN; Sengupta SR; Mehta MC
    Indian J Lepr; 1985; 57(4):767-72. PubMed ID: 3938987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical course of erythema nodosum leprosum: an 11-year cohort study in Hyderabad, India.
    Pocaterra L; Jain S; Reddy R; Muzaffarullah S; Torres O; Suneetha S; Lockwood DN
    Am J Trop Med Hyg; 2006 May; 74(5):868-79. PubMed ID: 16687695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A study of serum fibrinolytic activity in erythema nodosum leprosum (ENL).
    Jain VK; Verma KC; Aggarwal SS
    Lepr India; 1983 Jan; 55(1):95-9. PubMed ID: 6876766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased level of urinary nitric oxide metabolites in leprosy patients during type 2 reactions and decreased after antireactional therapy.
    Mohanty KK; Gupta M; Girdhar BK; Girdhar A; Chakma JK; Sengupta U
    Lepr Rev; 2007 Dec; 78(4):386-90. PubMed ID: 18309713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum levels of tumour necrosis factor-alpha and interleukin-1 beta during leprosy reactional states.
    Sarno EN; Grau GE; Vieira LM; Nery JA
    Clin Exp Immunol; 1991 Apr; 84(1):103-8. PubMed ID: 2015700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delayed-type hypersensitivity reactions followed by erythema nodosum leprosum.
    Rea TH; Sieling PA
    Int J Lepr Other Mycobact Dis; 1998 Sep; 66(3):316-27. PubMed ID: 9934358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum immune complexes in erythema nodosum leprosum reactions of leprosy.
    Rao TD; Rao PR
    Indian J Lepr; 1988 Apr; 60(2):189-95. PubMed ID: 3142953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utility of measuring serum levels of anti-PGL-I antibody, neopterin and C-reactive protein in monitoring leprosy patients during multi-drug treatment and reactions.
    Silva EA; Iyer A; Ura S; Lauris JR; Naafs B; Das PK; Vilani-Moreno F
    Trop Med Int Health; 2007 Dec; 12(12):1450-8. PubMed ID: 18076551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thalidomide levels in patients with erythema nodosum leprosum.
    Vieira JL; Valente Mdo S
    Ther Drug Monit; 2009 Oct; 31(5):602-3. PubMed ID: 19704404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.